| Name | 4-[4-(4-chlorophenyl)piperidin-4-yl]benzonitrile |
|---|---|
| Synonyms |
4-[4-(4-chloro-phenyl)-piperidin-4-yl]-benzonitrile
Benzonitrile,4-[4-(4-chlorophenyl)-4-piperidinyl] |
| Molecular Formula | C18H17ClN2 |
|---|---|
| Molecular Weight | 296.79400 |
| Exact Mass | 296.10800 |
| PSA | 35.82000 |
| LogP | 4.20998 |
|
~15%
857532-08-2 |
| Literature: ASTEX THERAPEUTICS LIMITED; THE INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL; CANCER RESEARCH TECHNOLOGY LIMITED Patent: WO2006/136821 A1, 2006 ; Location in patent: Page/Page column 133 ; WO 2006/136821 A1 |
|
~16%
857532-08-2 |
| Literature: ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED Patent: US2010/166699 A1, 2010 ; |